Dr. Reddy's Laboratories Limited Financials

Market Capitalization $11.59 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	17.68
Forward PE	21.86
Price to Sales TTM	$0.03
Price to Book MRQ	$2.87
Enterprise to Revenue	0.01
Enterprise to EBITDA	0.05

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2025-03-31
Most Recent Quarter	2025-09-30
Profit Margin	17.13%
Operating Margin	18.45%
Return on Assets TTM	8.78%
Return on Equity TTM	17.36%

Income Statement

Revenue TTM	$3,793,406,021
Revenue per Share TTM	$68.62
Quarterly Revenue Growth	9.80%
Gross Profit TTM	$2,140,700,126
EBITDA	$1,042,144,739
Net Income to Common TTM	$649,919,920
Diluted EPS TTM	$0.78
Quarterly Earnings Growth YoY	14.50%

Balance Sheet

Total Cash MRQ	$774,005,675
Total Cash per Share MRQ	$83.86
Total Debt MRQ	$
Total Debt to Equity MRQ	16.17
Current Ratio MRQ	1.85
Book Value per Share MRQ	$4.80

Cash Flow

Operating Cash Flow TTM	$652,115,153
Levered Free Cash Flow TTM	$150,371,593

RDY Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	832,515,335
Float Shares	600,310,158
Avg 10 Volume	849,383
Avg 30 Volume	None
Shares Short	10,105,577
Short Ratio	9.23
Short % of Shares	2.36%
% Held by Insiders	0.00%
% Held by Institutions	13.74%

Stock Price Summary

Beta	0.35
Fifty Two Week Low	$12.26
Fifty Two Week High	$16.17
Fifty Two Week Change	-11.26%
Day 50 MA	$13.98
Day 200 MA	$14.19

Dividends and Splits

Forward Annual Dividend Rate	$0.36
Forward Annual Dividend Yield	2.63%
Trailing Annual Dividend Rate	$0.09
Trailing Annual Dividend Yield	0.66%
Payout Ratio	11.41%
Dividend Date	2025-08-06
Ex Dividend Date	2025-07-25
Last Split Factor
Last Split Date	2024-11-05